Novel Experimental Agents for the Treatment of Hypercholesterolemia
Ivan Pećin,1,2 Željko Reiner1,2 1Zagreb School of Medicine, University of Zagreb, Zagreb, Croatia; 2Division of Metabolic Diseases, Department of Internal Medicine, University Hospital Center, Zagreb, CroatiaCorrespondence: Željko ReinerDivision of Metabolic Diseases, Department of Internal Medicine...
Saved in:
Main Authors: | Pećin I (Author), Reiner Ž (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulatory role of chelating agents in diet-induced hypercholesterolemia in rats
by: Heba M. Mahmoud, et al.
Published: (2014) -
Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia
by: Zhifu Xie, et al.
Published: (2023) -
Hypercholesterolemia
Published: (2015) -
Current Treatment Options in Homozygous Familial Hypercholesterolemia
by: Meral Kayikcioglu, et al.
Published: (2022) -
Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte's arginase activation
by: Gamaleldin I. Harisa, et al.
Published: (2017)